How a Master Neuron Controls Movement in Worms with Implications for Human Disease Apr 24, 2024 | Lunenfeld-Tanenbaum Research InstituteSinai Health researchers have uncovered a fascinating mechanism in the nervous system of the tiny roundworm Caenorhab...
Sinai Health’s Study Investigates Underuse of Breakthrough Diabetes Treatments Apr 15, 2024 | Lunenfeld-Tanenbaum Research Institute, Sinai HealthDespite their potential to transform type 2 diabetes (T2D) management, the adoption of new medications like SGLT2 inh...
Sinai Health Researchers to Trial Volunteer Support for Stroke Recovery Apr 10, 2024 | Hennick Bridgepoint Hospital, Lunenfeld-Tanenbaum Research Institute, Media Releases, Sinai HealthA stroke is often life-changing for patients and their families. Fatigue, mobility issues, incontinence, depression, ...
Toronto researchers devise new method to find proteins for targeted treatment of disease Mar 29, 2024 | Lunenfeld-Tanenbaum Research InstituteFrom left to right: Drs. Anne-Claude Gingras, Mikko Taipale and Daniel Schramek.Researchers at the University of Toro...
Sinai Health’s $10M funding fuels creation of lab-grown organoids for disease research and drug discovery Mar 21, 2024 | Lunenfeld-Tanenbaum Research Institute, Media ReleasesLab-grown human brain organoid tissue derived entirely from stem cells. The left panel is a low power view, the right...
Dr. Ross Upshur completes tenure as head of research at Hennick Bridgepoint Mar 19, 2024 | Hennick Bridgepoint Hospital, Lunenfeld-Tanenbaum Research Institute, Mount Sinai HospitalDr. Ross Upshur can reflect with pride as he completes his term as Scientific Director of the Bridgepoint Collaborato...